Source: University of California - San Francisco
Date: September 1, 2009
Summary:
UCSF scientists have demonstrated that adult human mesenchymal stem cells reverse the effects of injury in a novel human lung preparation in the lab. The finding, they say, could lead to the development of stem cell therapies for patients with acute lung injury and acute respiratory distress syndrome, conditions that presently have a high rate of mortality and no pharmacological treatments. Their study is published in the September 1 issue of the Proceedings of the National Academy of Sciences.
